文献
J-GLOBAL ID:202202268519534057
整理番号:22A0729292
ダパグリフロジンはヒト内皮細胞および分化マクロファージにおけるLPS誘発TLR-4過剰発現およびNF-κB活性化の阻害を介して抗炎症効果を発揮する【JST・京大機械翻訳】
Dapagliflozin exerts anti-inflammatory effects via inhibition of LPS-induced TLR-4 overexpression and NF-κB activation in human endothelial cells and differentiated macrophages
著者 (8件):
Abdollahi Elaheh
(Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Hemmat Highway, Tehran, Iran)
,
Keyhanfar Fariborz
(Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Hemmat Highway, Tehran, Iran)
,
Delbandi Ali-Akbar
(Department of Immunology, School of Medicine, Iran University of Medical Sciences, Hemmat Highway, Tehran, Iran)
,
Delbandi Ali-Akbar
(Immunology Research Center, Institute of Immunology and Infectious Disease, Iran University of Medical Sciences, Tehran, Iran)
,
Falak Reza
(Department of Immunology, School of Medicine, Iran University of Medical Sciences, Hemmat Highway, Tehran, Iran)
,
Falak Reza
(Immunology Research Center, Institute of Immunology and Infectious Disease, Iran University of Medical Sciences, Tehran, Iran)
,
Hajimiresmaiel Seyed Javad
(Department of Cardiology, Iran University of Medical Sciences, Tehran, Iran)
,
Shafiei Massoumeh
(Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Hemmat Highway, Tehran, Iran)
資料名:
European Journal of Pharmacology
(European Journal of Pharmacology)
巻:
918
ページ:
Null
発行年:
2022年
JST資料番号:
B0841A
ISSN:
0014-2999
CODEN:
EJPHAZ
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)